Category Archives: Events

Latest From Events

Governor Chris Christie Will Headline BioNJ 2012 Annual Meeting

christie-btn

BioNJ, the trade association for New Jersey’s biotechnology industry, will welcome New Jersey Governor Chris Christie to address attendees at the association’s 2012 Annual Dinner Meeting, Awards Program and Networking Event on Thursday, February 2. The event will be held at the East Brunswick Hilton in East Brunswick, NJ beginning at 5:00 p.m. Celebrating its 19th anniversary in 2012, the BioNJ Annual Dinner Meeting, Awards Program and Networking event with its theme of Friends Hope Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

State Biotech Advocates Share Best Practices

CSBA

Last week the Council of State Bioscience Associations (CSBA) held its annual retreat in Austin, TX, where 42 different state-based bioscience advocacy organization gathered to discuss legislative and regulatory best practices that support bioscience industry development. More than 90 invited participants engaged in discussions covering the topics of economic development initiatives, upcoming federal and state legislative industry priorities, and advocacy campaigns in the digital era. BIO’s State Government Relations team would like to once again Read More >

Events  |  1 Comment  |  Email This Post
Tags: , , ,

4 Keys for Partnering Success

BIO Exhibition - 2011 BIO International Convention

Thinking of hosting partnering meetings at your BIO Exhibition booth in 2012? Abbott has been there, done that and learned what it takes to succeed and secure high-quality leads. “The greatest value of hosting partnering meetings within our booth is that it allows us to drive traffic, activity and interest within our own space,” said Michelle Calhoun, Abbott’s contract manufacturing marketing director. Abbott hosted nearly 60 meetings within our booth during three days of partnering Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Beyond the ABCs of ADCs

Antibody

The recent FDA approval of Seattle Genetics’ antibody, Adcetris, has cast the spotlight on Antibody Drug Conjugates (ADC), leaving experts to contemplate whether this is the peak for ADCs. If history has its say though, the spotlight won’t be flickering anytime soon. Experts in this specialized antibody field discussed the latest developments and lessons of bringing ADCs through the clinic at this week’s 10th Annual BIO Investor Forum. Antibody drug conjugates hold enormous potential for treating Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Multiple Assets Diversify the Deal

Partnering Meeting

With a recent surge in pharma companies collaborating earlier on with small biotech companies, discovery stage partnering deals are becoming increasingly popular.  Striking a discovery stage deal can be extremely beneficial for both parties in today’s environment – pharma gets to fill its ever elusive R&D pipeline as patent expirations loom, and the small biotech struggling to raise money to stay alive gets the capital infusion necessary to stay in play. Panelists in the “Broad Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,